NL6802594A - - Google Patents

Info

Publication number
NL6802594A
NL6802594A NL6802594A NL6802594A NL6802594A NL 6802594 A NL6802594 A NL 6802594A NL 6802594 A NL6802594 A NL 6802594A NL 6802594 A NL6802594 A NL 6802594A NL 6802594 A NL6802594 A NL 6802594A
Authority
NL
Netherlands
Application number
NL6802594A
Other versions
NL142073B (en
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NL6802594A publication Critical patent/NL6802594A/xx
Publication of NL142073B publication Critical patent/NL142073B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NL6802594A 1967-02-24 1968-02-23 PROCESS FOR THE PREPARATION OF A CARRIER CONTAINING A HYDROXYALKYLCELLULOSIS, FORMED MEDICINAL PRODUCT AND FORMED MEDICINAL PRODUCT THEREFORE OBTAINED. NL142073B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB900467A GB1171691A (en) 1967-02-24 1967-02-24 Lond-Acting Oral Carrier

Publications (2)

Publication Number Publication Date
NL6802594A true NL6802594A (en) 1968-08-26
NL142073B NL142073B (en) 1974-05-15

Family

ID=9863505

Family Applications (1)

Application Number Title Priority Date Filing Date
NL6802594A NL142073B (en) 1967-02-24 1968-02-23 PROCESS FOR THE PREPARATION OF A CARRIER CONTAINING A HYDROXYALKYLCELLULOSIS, FORMED MEDICINAL PRODUCT AND FORMED MEDICINAL PRODUCT THEREFORE OBTAINED.

Country Status (5)

Country Link
BE (1) BE711241A (en)
DE (1) DE1667888C3 (en)
DK (1) DK122997B (en)
GB (1) GB1171691A (en)
NL (1) NL142073B (en)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1018456A (en) * 1972-06-26 1977-10-04 Hans Lowey Prolonged release lozenges
DE2530563C2 (en) * 1975-07-09 1986-07-24 Bayer Ag, 5090 Leverkusen Analgesic drugs with reduced potential for abuse
GB1593261A (en) 1976-07-23 1981-07-15 Inveresk Res Int Controlled release suppository
US4163777A (en) * 1977-04-29 1979-08-07 Lewis/Howe Company Controlled antacid delivery form and method of treatment therewith
US4226849A (en) 1979-06-14 1980-10-07 Forest Laboratories Inc. Sustained release therapeutic compositions
US4357469A (en) 1979-06-14 1982-11-02 Forest Laboratories, Inc. Carrier base material for prolonged release therapeutic compositions
US4259314A (en) 1979-12-10 1981-03-31 Hans Lowey Method and composition for the preparation of controlled long-acting pharmaceuticals
US4369172A (en) * 1981-12-18 1983-01-18 Forest Laboratories Inc. Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose
US4680323A (en) * 1983-12-01 1987-07-14 Hans Lowey Method and composition for the preparation of controlled long-acting pharmaceuticals for oral administration
US5855908A (en) * 1984-05-01 1999-01-05 University Of Utah Research Foundation Non-dissolvable drug-containing dosage-forms for use in the transmucosal delivery of a drug to a patient
US4863737A (en) * 1985-05-01 1989-09-05 University Of Utah Compositions and methods of manufacture of compressed powder medicaments
US4885173A (en) 1985-05-01 1989-12-05 University Of Utah Methods and compositions for noninvasive dose-to-effect administration of drugs with cardiovascular or renal vascular activities
US5122127A (en) * 1985-05-01 1992-06-16 University Of Utah Apparatus and methods for use in administering medicaments by direct medicament contact to mucosal tissues
US5288497A (en) * 1985-05-01 1994-02-22 The University Of Utah Compositions of oral dissolvable medicaments
US5132114A (en) * 1985-05-01 1992-07-21 University Of Utah Research Foundation Compositions and methods of manufacture of compressed powder medicaments
GB8514665D0 (en) * 1985-06-11 1985-07-10 Eroceltique Sa Oral pharmaceutical composition
US4764378A (en) * 1986-02-10 1988-08-16 Zetachron, Inc. Buccal drug dosage form
US4775535A (en) * 1986-04-04 1988-10-04 Hans Lowey Method of preparing controlled long-acting pharmaceutical formulations in unit dosage form having uniform and comparable bioavailability characteristics
US4855143A (en) * 1986-04-04 1989-08-08 Hans Lowey Method of preparing controlled long-acting pharmaceutical formulations in unit dosage form having uniform and comparable bioavailability characteristics
FR2621483B1 (en) * 1987-10-08 1991-09-20 Medibrevex NOVEL GALENIC FORMS OF CORTICOIDS FOR PER- AND SUBLINGUAL ADMINISTRATION AND THEIR PREPARATION PROCESS
GB8802391D0 (en) * 1988-02-03 1988-03-02 Ddsa Pharmaceuticals Ltd Medicinal formulations
US5713852A (en) * 1995-06-07 1998-02-03 Alza Corporation Oral dosage and method for treating painful conditions of the oral cavity

Also Published As

Publication number Publication date
DE1667888C3 (en) 1978-07-13
DE1667888B2 (en) 1977-11-10
DE1667888A1 (en) 1971-07-22
BE711241A (en) 1968-07-01
DK122997B (en) 1972-05-08
GB1171691A (en) 1969-11-26
NL142073B (en) 1974-05-15

Similar Documents

Publication Publication Date Title
AT298283B (en)
FR1589378A (en)
AU2454867A (en)
AU1273466A (en)
AU2116667A (en)
BE701980A (en)
BE477645A (en)
AU23366A (en)
BE692779A (en)
AU1614766A (en)
AU1677166A (en)
BE711481A (en)
BE711307A (en)
AU1763766A (en)
NL6802594A (en)
BE710355A (en)
BE709784A (en)
BE709146A (en)
BE709060A (en)
BE708658A (en)
BE708183A (en)
BE707040A (en)
BE692654A (en)
BE703754A (en)
BE692375A (en)

Legal Events

Date Code Title Description
SNR Assignments of patents or rights arising from examined patent applications
NL80 Abbreviated name of patent owner mentioned of already nullified patent

Owner name: FOREST LAB

V4 Lapsed because of reaching the maxim lifetime of a patent